Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan
· Delayed Price · Currency is TWD 64.70
+0.30 (0.47%)
Apr 24, 2025, 1:30 PM CST
Foresee Pharmaceuticals Revenue
In the year 2024, Foresee Pharmaceuticals had annual revenue of 418.69M TWD with 114.67% growth. Foresee Pharmaceuticals had revenue of 140.55M in the quarter ending December 31, 2024, with 105.41% growth.
Revenue
418.69M
Revenue Growth
+114.67%
P/S Ratio
23.92
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 418.69M | 223.65M | 114.67% |
| Dec 31, 2023 | 195.04M | -106.47M | -35.31% |
| Dec 31, 2022 | 301.51M | 75.48M | 33.39% |
| Dec 31, 2021 | 226.03M | -4.41M | -1.91% |
| Dec 31, 2020 | 230.44M | 155.24M | 206.44% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.82B |
| Lumosa Therapeutics | 39.15M |